Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Yajne on Apr 19, 2023 6:26pm

Volume today

although volume was low, looks like it traded all over the map when looking at all Cdn exchanges. A total of 45 trades today on all Cdn exchanges

V:TLT - Theralase Technologies Inc. - https://www.theralase.com
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
TLT - V   6.5 0.265 · 0.28 10.0 0.28 +0.045 19.1 100.4 23 45 0.235  0.30  0.23 0.43  0.23 15:59:59 Feb 23 15 min RT 2¢
TSX-V - V 6.5 0.265 · 0.28 10.0 0.265 +0.03 12.8 45.1 11 18 0.235  0.30  0.235 0.43  0.23 15:57:46   15 min 
NEO ATS - U   0.25 +0.015 6.4 26.5 6 8 0.235  0.25  0.235   13:29:13   15 min 
Alpha - A   0.28 +0.045 19.1 1.0 0 1 0.28  0.28  0.28   15:59:59   15 min 
Omega - O   0.26 +0.025 10.6 16.5 4 5 0.25  0.26  0.25   15:14:43   15 min 
Pure - P   0.235     0.5   2        Aug 26   15 min 
Chi-X - X   0.255 +0.02 8.5 0.5 0 1 0.255  0.255  0.255   14:19:11   15 min 
CX2 - H   0.27 +0.035 14.9 9.5 2 5 0.23  0.27  0.23   15:57:46   15 min 
CXD - D   0.235     0.5   2        Apr 18   15 min 
TriAct - M   0.235     0.4 0 3            15 min
Comment by ScienceFirst on Apr 19, 2023 8:28pm
Good observation Yajne. It would be interesting to assess if that's usually the case (a 55% spread on other exchanges).  There was also higher than normal volume on the US side, though nothing out of the ordinary. Worth following, just to see if there's a growing trend, ahead the next round of data and AUA congress.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250